Progress in the Chronotherapy of Nocturnal Asthma

  • M. H. Smolensky
  • G. E. D’Alonzo
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 125)

Abstract

Bronchial asthma is a chronic airways disease. Symptoms include dyspnea, wheezy chest, cough, and fatigue. It is seldom a problem for those who suffer from the mild form of the disease. However, it is a significant and even life-threatening one for those prone to severe asthma. Asthma is characterized by persistent airways inflammation, airways hyperreactivity, and compromised pulmonary function (Martin 1993). All are reversible, at least to some extent, with medication and environmental control. Asthma severity varies between patients and even in the same patient over time. Most patients experience worsening of symptoms during the night; many experience symptoms only at night (Dethlefsen and Repges 1985; Turner-Warwick 1988). Successful asthma management must address the major features of the disease — airways inflammation and hyperreactivity, compromised pulmonary function, and temporal patterning.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams F (ed. and trans.) (1856) The extant works of Aretaeus. The Cappadocian. London: Printed for the Syndenham SocietyGoogle Scholar
  2. Anonymous (1982) Death from asthma in two regions of England. Br Med J 285: 1251–1255CrossRefGoogle Scholar
  3. Arvidsson P, Larsson S, Lofdahl CG Melander B, Svedmyr N, Wahlander L (1991) Inhaled formoterol during one year in asthma: a comparison with salbutamol. Eur Respir J 4: 1168–1173PubMedGoogle Scholar
  4. Babb RR, Notarangelo J, Smith VM (1970) Wheezing as a clue to gastroesophageal reflux. Am J Gastroenterol 53: 230–233PubMedGoogle Scholar
  5. Ball DI, Brittain RT, Coleman RA, Denyer LH, Jack D, Johnson M, Lunts LHC, Nials, AT, Sheldrick KE, Skidmore IF (1991) Salmeterol, a novel, long-acting beta2-adrenergic agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol 104: 665–671PubMedCrossRefGoogle Scholar
  6. Ballard RD (1993) Effects of sleep on respiratory physiology in nocturnal asthma. In: Martin RJ (ed) Nocturnal asthma: mechanisms and treatment. Futura Publ. Co. Mt Kisco, NYGoogle Scholar
  7. Ballard RD, Saathoff MC, Patel DK, Kelly PL, Martin RJ (1989) Effects of sleep on nocturnal bronchoconstriction and ventillatory patterns in asthmatics. J Appl Physiol 67: 243–249PubMedGoogle Scholar
  8. Barnes PJ (1990) Effect of corticosteroids on airway hyperresponsiveness. Am Rev Respir Dis 141: S70–76PubMedGoogle Scholar
  9. Barnes Pi (1995) Inhaled glucocorticods for asthma. N Engl J Med 332: 868–875CrossRefGoogle Scholar
  10. Barnes Pi, Pauwels RA (1994) Theophylline in the management of asthma: time for reappraisal? Eur Respir J 7: 579–591CrossRefGoogle Scholar
  11. Barnes Pi, Fitzgerald G, Brown M, Dollery C (1980) Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med 303: 263–267CrossRefGoogle Scholar
  12. Barnes PJ, Fitzgerald GA, and Dollery CT (1982) Circadian variation in adrenergic response in asthmatic subjects. Clin Sci 62: 349–354PubMedGoogle Scholar
  13. Bateman JRM, Clark SW (1979) Sudden death in asthma. Thorax 34: 40–44PubMedCrossRefGoogle Scholar
  14. Beam WR, Weiner DE, Martin RJ (1992) Timing of prednisone and alteration of airways inflammation in nocturnal asthma. Am Rev Respir Dis 146: 1524–1530PubMedGoogle Scholar
  15. Bogin RM, Ballard RD (1992) Treatment of nocturnal asthma with pulse-release albuterol. Chest 102: 362–366PubMedCrossRefGoogle Scholar
  16. Bollinger AM, Young KYL, Gambertoglio JG, Newth CJL, Zureikat G, Powell M, Leung P, Affirme MB, Symchowicz S, Patrick JE (1989) Influence of food on the absorption of albuterol Repatabs. J Allergy Clin Immunol 83: 123–126CrossRefGoogle Scholar
  17. Bonnet R, Jorres R, Heitmann U, Mangnussen H (1991) Circadian rhythm in airway responsiveness and airway tone in patients with mild asthma. J Appl Physiol 71: 1598–1605PubMedGoogle Scholar
  18. Brambilla C, Chastang C, Georges D, Bertin L (1994) Salmeterol compared with slow-release terbutaline in nocturnal asthma. Allergy 49: 421–426PubMedCrossRefGoogle Scholar
  19. British Thoracic Society (1993) Guidelines on management of asthma. Thorax48(Suppl): 1098–1111Google Scholar
  20. Britton MG, Earnshaw JS, Palmer JBD (1992) A twelve month comparison of salmeterol and salbutamol in asthmatic patients. Eur Respir J 5: 1062–1067PubMedGoogle Scholar
  21. Brown A, Smolensky M, D’Alonzo G, Frankoff H, Gianotti L, Nilsestuen J (1988) Circadian chronesthesy of the airways of healthy adults to the 13-agonist bronchodilator isoproterenol. Ann Rev Chronopharmacol 5: 163: 166Google Scholar
  22. Busse WW, Bush RK (1988) Comparison of Uniphyl tablets and inhaled albuterol as maintenance therapy in asthmatic adults. Am J Med 85 (Suppl 1B): 10CrossRefGoogle Scholar
  23. Butchers PR, Cousins SA, Vardey CJ (1987) Salmeterol: a potent and long-acting inhibitor of the release of inflammatory and spasmogenic mediators from human lungs. Br J Pharmacol 92 (Suppl): 745P (abstract)Google Scholar
  24. Calhoun WJ, Bates ME, Schrader L, Sedgwick JB, Busse WW (1992) Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. Am Rev Respir Dis 145: 577–581PubMedGoogle Scholar
  25. Callaghan B, Teo NC, Clancy L (1992) Effects of the addition of nedocromil sodium to maintenance bronchodilator therapy in management of chronic asthma. Chest 101: 787–792PubMedCrossRefGoogle Scholar
  26. Catterall JL, Rhind GB, Whyte KF, Shapiro CM, Douglas NJ (1988) Is nocturnal asthma caused by changes in airway cholinergic activity? Thorax 43: 720–724PubMedCrossRefGoogle Scholar
  27. Ceresa F, Angeli A, Boccuzzi A, Molino G (1969) Once-a-day neurally stimulated and basal ACTH secretion phases in man and their responses to corticoid inhibition. J Clin Endocrinol Metab 29: 1074–1082PubMedCrossRefGoogle Scholar
  28. Chan CS, Woolcock AL, Sullivan CE (1988) Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 137: 1502–1504PubMedGoogle Scholar
  29. Chaplin MD, Rooks W II, Swenson EW, Cooper WC, Nerenberg C, Chu NI (1980) Flunisolide metabolism and dynamics of a metabolite. Clin Pharmacol Ther 27: 402–413PubMedCrossRefGoogle Scholar
  30. Cochrane GM and Clark TJH (1975) A survey of asthma mortality in patients between 35 and 65 years in the greater London hospitals in 1971. Thorax 30: 300–315PubMedCrossRefGoogle Scholar
  31. Cockcroft DW, Hoeppner VH, Werner GD (1984) Recurrent nocturnal asthma after bronchoprovocation with western red cedar sawdust: association with acute increase in non-allergic bronchial responsiveness. Clin Allergy 14: 61–68PubMedCrossRefGoogle Scholar
  32. Coe CI, Barnes PJ (1986) Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest 90: 485–488PubMedCrossRefGoogle Scholar
  33. Cox ID, Hughes DTD, McConnell K (1984) Ipratropium bromide in patients with nocturnal asthma. Postgrad Med J 60: 526–528PubMedCrossRefGoogle Scholar
  34. Creemers JD (1988) A multicenter comparative study of salbuterol controlled release (Volmax) and sustained-release theophyllin (Theo-Dur) in the control of nocturnal asthma. Eur Respir J l(Suppl 2 ): 333s (Abstract)Google Scholar
  35. Crepaldi G, Muggeo M (1974) Plurichronocorticoid treatment of bronchial asthma and chronic bronchitis. Clinical and endocrinometabolic evaluation. Chronobiologia l(Suppl. 1 ): 407–427Google Scholar
  36. D’Alonzo GE, Smolensky MH, Feldman S, Gianotti LA, Emerson MB, Staudinger H, Steinijans VM (1990) Twenty-four-hour lung function in adult patients with asthma: chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing. Am Rev Respir Dis 142: 84–90PubMedGoogle Scholar
  37. D’Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Rathner P, Rennard SI (1994) Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 271: 1412–1416PubMedCrossRefGoogle Scholar
  38. D’Alonzo GE, Smolensky MH, Feldman S, Gnosspelius Y, Karlsson K (1995) Barnbuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration. Chest 107: 406–412Google Scholar
  39. Dahl R, Johansson S-A (1982) Clinical effect of b.i.d. and q.i.d. administration of inhaled budesonide, a double-blind controlled study. Eur J Respir Dis 63 (Suppl 122): 268–269Google Scholar
  40. Dahl R, Harving H, Sawedal L, Anchus S. (1988) Terbutaline sustained-release tablets in nocturnal asthma–a placebo-controlled comparison between a high and low evening dose. Br J Dis Chest 82: 237–241PubMedCrossRefGoogle Scholar
  41. Dahl R, Pedersen B, Venge P (1991) Bronchoalveolar lavage studies. Eur Respir Rev 1: 272–275Google Scholar
  42. Darow P, Steinijans VW (1987) Therapeutic advantage of unequal dosing of theophylline in patients with nocturnal asthma. Chronobiol Intern’l 4: 349–357CrossRefGoogle Scholar
  43. Davies KJ, Green M, Schofield NM (1976) Recurrent nocturnal asthma after exposure to grain dust. Am Rev Dis 114: 1011–1019Google Scholar
  44. DeMonchy JGR, Kauffman HF, Vernge P, Koeter GH, Jansen HM, Sluiter Hi, DeVries KD (1985) Bronchoalveolar eosinophilia during allergen-induced late asthmatic reaction. Am Rev Respir Dis 131: 373–376Google Scholar
  45. Derom E, Pauwels R, Van Der Straeten M (1990) Duration of the protective effect of salmeterol on methacholine challenge of asthmatics. Am Rev Respir Dis 141 (Suppl): A469 (Abstract)Google Scholar
  46. Dethlefsen U, Repges R (1985) Ein neues Therapieprinzip bei nächtlichem Asthma. Med Klin 80: 44–47Google Scholar
  47. DeVries KJT, Goei H, Booy-Noord H, Orie NGM (1962) Changes during 24 hours in lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. Arch Allergy Appl Immunol 20: 93–101CrossRefGoogle Scholar
  48. Douglas NJ (1985) Asthma at night. Clin Chest Med 6: 663–674PubMedGoogle Scholar
  49. English J, Marks V (1981) Diurnal variations in methylprednisolone metabolism in the rat. IRCS Med Sci 9: 721Google Scholar
  50. English J, Dunne M, Marks V (1983) Diurnal variation in prednisone kinetics. Clin Pharmacol Ther 33: 381–385PubMedCrossRefGoogle Scholar
  51. Eriksson NE, Haglind K, Ljungholm K (1982) A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthma. Br J Dis Chest 76: 202–204PubMedCrossRefGoogle Scholar
  52. Eriksson L, Jonson B, Eklundh G, Persson G (1988) Nocturnal asthma: effects of slowrelease terbutaline on spirometry and arterial blood gases. Eur Respir J 1: 302–305PubMedGoogle Scholar
  53. Faurschou P, Engel A-M, Haanaes OC (1994) Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies. Allergy 49: 827–832PubMedCrossRefGoogle Scholar
  54. Finnerty JP, Twentyman OP, Holgate ST (1991) The duration of action of salmeterol as a bronchodilator and functional antagonist of histamine-induced bronchoconstriction. Am Rev Respir Dis 143 (4pt2): A654 (Abstract)Google Scholar
  55. Fitzgerald GA, Barnes P, Brown, MJ, Dollery CT (1980) The circadian variability of circulating adrenaline and bronchomotor reactivity in asthma. In: Smolensky MH, Reinberg A, Labrecque G (eds) Recent advances in chronobiology of allergy and immunology. Pergamon, Oxford, pp 89–94Google Scholar
  56. Fitzpatrick MF, Mackay T, Driver H, Douglas NJ (1990) Salmeterol in nocturnal asthma: a double-blind, placebo controlled trial of a long acting inhaled 132 agonist. Br Med J 301: 1365–1368CrossRefGoogle Scholar
  57. Floyer J (1689) A treatise of the asthma. Wilkin, LondonGoogle Scholar
  58. Furukawa CT, Shapiro GG, Bierman CW, Kraemer MJ, Ward DJ, Pierson WE (1984) A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics 74: 453–459PubMedGoogle Scholar
  59. Gaultier C, Reinberg A, Girard F (1975) Circadian changes in lung resistance and dynamic compliance in healthy and asthmatic children. Effects of two bronchodilators. Resp Physiol 31: 169–182Google Scholar
  60. Gaultier C, Reinberg A, Motohashi Y (1988) Circadian rhythm in total pulmonary resistance of asthmatic children. Effects of a (3-agonist agent. Chronobiol Intern’l 5: 285–290CrossRefGoogle Scholar
  61. Gervais P, Reinberg A, Gervais C, Smolensky MH, Defrance 0 (1977) Twenty-four-hour rhythm in the bronchial hyperreactivity to house dust in asthmatics. J Allergy Clin Immunol 59: 207–213Google Scholar
  62. Goldenheim PD, Conrad EA, Schein LK (1987) Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing. Chronobiol Intern’l 4: 397–408CrossRefGoogle Scholar
  63. Goodall RJR, Earis JE, Cooper DN, Bernstein A, Temple JG (1981) Relationship between asthma and gastroesophageal reflux. Thorax 36: 116–121PubMedCrossRefGoogle Scholar
  64. Goo RH, Moore JG, Greenberg E, Alazraki NP (1987) Circadian variation in gastric emptying of meals in man. Gastroenterology 93: 515–518PubMedGoogle Scholar
  65. Gonzalez JP, Brogden RH (1987) Nodocromil sodium: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible airways disease. Drugs 34: 560–577PubMedCrossRefGoogle Scholar
  66. Grossman J, Morris RJ, White KD, Cocchetto M (1991) Improved stability in oral delivery of albuterol provides less variability in bronchodilation in adults with asthma. Ann Allergy 66: 324–327PubMedGoogle Scholar
  67. Harkness JAL, Richter MB, Pamayi GS, Van DePete K, Unger K, Pownall R, Geddawi M (1982) Circadian variation in disease activity in rheumatoid arthritis. Br Med J 284: 551–554CrossRefGoogle Scholar
  68. Harter JG, Reddy WIJ, Thorn GW (1963) Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 296: 591–595CrossRefGoogle Scholar
  69. Hetzel MR, Clark TJH (1980) Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 35: 732–738PubMedCrossRefGoogle Scholar
  70. Hetzel MR, Clark TJH, Branthwaite MA (1977) Asthma: analysis of sudden deaths and ventilatory arrest in hospital. Br Med J 1: 808–811PubMedCrossRefGoogle Scholar
  71. Hetzel MR, Clarke JH, Gilliam SJ, Isaac P, Perkins M (1985) Is sodium cromoglycate effective in nocturnal asthma? Thorax 40: 793: 794Google Scholar
  72. Higenbottam MA, Khan A, Williams DO, Mikhail JR, Peake MD, Hughes J (1989) Controlled release salbutamol tablets versus aminophylline in the control of reversible airways obstruction. J Int Med Res 17: 435–441PubMedGoogle Scholar
  73. Holliday SM, Faulds D, Sorkin EM (1994) Inhaled fluticasone propionate: a review of its pharmacodynamics and pharmacokinetic properties, and therapeutic use in asthma. Drugs 47: 319–331CrossRefGoogle Scholar
  74. Hussey EK, Donn KH, Powell JR (1991) Albuterol extended-release products: a comparison of steady-state pharmacokinetics. Pharmacotherapy 11: 131–135PubMedGoogle Scholar
  75. Jarjour NN, Calhoun WJ, Busse WW (1992) Enhanced metabolism of oxygen radicals in nocturnal asthma. Am Rev Respir Dis 146: 905–911PubMedGoogle Scholar
  76. Joad JP, Ahrens RC, Lindgren SD, Weinberger MM (1987) Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma. J Allergy Clin Immunol 79: 78–85PubMedCrossRefGoogle Scholar
  77. Johnson M (1991) The preclinical pharmacology of salmeterol: bronchodilator effects. Eur Respir Rev 1: 253–256Google Scholar
  78. Johnson M, Butchers PR, Vardey CJ (1991) Potency and duration of action of salmeterol as an inhibitor of mediator release from human lung. Am Rev Respir Dis 143 (4pt2): A655 (abstract)Google Scholar
  79. Johnson M, Butchers PR, Whelan CJ (1992) The therapeutic potential of long-acting beta2-adrenoceptor agonists in allergic inflammation. Clin Exp Allergy 22: 177–181PubMedCrossRefGoogle Scholar
  80. Kay AM (1987) The mode of action of anti-allergic drugs. Clin Allergy 17: 154–164Google Scholar
  81. Kesten S, Chapman KR, Broder I, Cartier A, Hyland RH (1992) Sustained improvement in asthma with long-term use of formoterol fumarate. Ann Allergy 69: 415–420PubMedGoogle Scholar
  82. Kemp JP, Bierman CW, and Cocchetto DM (1993) Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and holter monitoring. Ann Allergy 70: 316–322PubMedGoogle Scholar
  83. Kidney JC, Dominguez M, Rose M, Aikman S, Chung K, Barnes PJ (1994) Withdrawing chronic theophylline treatment increases airway lymphocytes in asthma. Thorax 49: 396Google Scholar
  84. Koeter GH, Postma DS, Keyzer JJ, Meurs H (1985) Effect of oral slow-release terbutaline on early morning dyspnea. Eur J Clin Pharmacol 28: 159–162PubMedCrossRefGoogle Scholar
  85. Kraft M, Torvik JA, Trudeau J, Wenzel SE, Martin RJ (1996) Theophylline potential anti-inflammatory effects in nocturnal asthma. J Allergy Clin Immunol (97: 1242–1246 )Google Scholar
  86. Kyle GM, Smolensky, MH, McGovern JP (1979) Circadian variation in the susceptibility of rodents to the toxic effects of theophylline. In: Reinberg A, Halberg F (eds) Chronopharmacology, Pergamon, Oxford, pp 239–244Google Scholar
  87. Labrecque G, Reinberg A (1989) Chronopharmacology of nonsteroidal anti-inflammatory drugs. In: Lemmer B(ed), Chronopharmacology. Cellular and biochemical interactions. Marcel Dekker, New York pp 545–579Google Scholar
  88. Lemmer B, Bruguerolle B (1994) Chronopharmacokinetics: are they clinically relevant. Clin Pharmacokinet 26: 419–427PubMedCrossRefGoogle Scholar
  89. Lemmer B, Nold G1991 Circadian changes in estimated hepatic) blood flow in health g P Ysubjects. Br J Clin Pharmacol 32: 627–629Google Scholar
  90. Levi F, LeLouarn C, Reinberg A (1985) Timing optimized sustained indomethacin treatment of osteoarthritis. Clin Pharmacol Ther 37: 77–84PubMedCrossRefGoogle Scholar
  91. Lundback B, Rawlinson DW, Palmer JBD (1993) Twelve month comparison of sal-meterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 48: 148–153PubMedCrossRefGoogle Scholar
  92. Maconochie JG, Forster JK, Fowler P, Thomas M (1988) An initial comparison of salmeterol and salbutamol against histamine-induced bronchoconstriction in healthy subjects. Br J Clin Pharm 25: 115P (abstract)Google Scholar
  93. Maesen FPV, Smeets JJ (1986) Comparison of a controlled-release tablet of salbutamol given twice daily with a standard tablet given four times daily in the management of chronic obstructive lung disease. Eur Respir J 31: 431–436Google Scholar
  94. Maesen FBV, Smeets JJ, Gubbelmans HLL, Zweers PGMA (1990a) Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours. Chest 97: 590–594PubMedCrossRefGoogle Scholar
  95. Maesen FBV, Smeets JJ, Gubbelmans HLL, Zweers PGMA (1990b) Formoterol in the treatment of nocturnal asthma. Chest 98: 866–870PubMedCrossRefGoogle Scholar
  96. Malo J-L, Cartier A, Merland N, Ghezzo H, Burek A, Morris J, Jennings BH (1989) Four-times-a-day dosing frequency is better than twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma. Am Rev Respir Dis 140: 624–628PubMedGoogle Scholar
  97. Malo J-L, Ghezzo H, Trudeau C, L’Archeveque J, Cartier A (1992) Salmeterol, a new inhaled beta2-adrenergic agonist, has longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction. J Allergy Clin Immunol 89: 567–574PubMedCrossRefGoogle Scholar
  98. Martin ME, Grunstein MM, Larsen GL (1982) The relationship of gastroesophageal reflux to nocturnal wheezing in children with asthma. Ann Allergy 49: 318–322PubMedGoogle Scholar
  99. Martin RJ (ed) (1993) Nocturnal asthma Mechanisms and treatment. Futura, Mount Kisco, NYGoogle Scholar
  100. Martin RJ, Cicutto LC, Ballard RD, Goldenheim PD, Cherniack RM (1989) Circadian variations in theophylline concentrations and the treatment of nocturnal asthma. Am Rev Respir Dis 139: 475–478PubMedCrossRefGoogle Scholar
  101. Martin RJ, Cicutto LC, Ballard RD (1990) Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis 141: 33–38PubMedGoogle Scholar
  102. Martin RJL, Cicutto LC, Smith HR, Ballard RD, Szefler SJ (1991) Airways inflammation in nocturnal asthma. Am Rev Respir Dis 143: 351–357PubMedGoogle Scholar
  103. McAllister WAC, Mitchell DM, Collins JV (1981) Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects. Br J Clin Pharmacol 11: 303–304PubMedCrossRefGoogle Scholar
  104. Mohiuddin AA, Martin RJ (1990) Circadian basis of the late asthma response. Am Rev Respir Dis 142: 1153–1157PubMedGoogle Scholar
  105. Moore JG, Englert E (1970) Circadian rhythm of gastric acid secretion in man. Nature 226: 1261–1262PubMedCrossRefGoogle Scholar
  106. Moore-Gillon J (1988) Volmax (salbutamol CR 8 mg) in the management of nocturnal asthma: a placebo-controlled study. Eur Respir J 1 (Suppl 2): 306s (Abstract)Google Scholar
  107. Morgan AD, Connaughton JJ, Caterall JR, Shapiro CM, Douglas NJ, Flenley DC (1986) Sodium cromoglycate in nocturnal asthma. Thorax 41: 39–41PubMedCrossRefGoogle Scholar
  108. Morrison JFJ, Pearson SB, Dean HG (1988) Parasympathetic nervous system in nocturnal asthma. Br Med J 296: 1427–1429CrossRefGoogle Scholar
  109. Morselli PL, Marc V, Garattini S, Zaccala M (1970) Metabolism of exogenous cortisol in humans-diurnal variations in plasma disappearance rate. Biochem Pharmacol 19: 1643–1647PubMedCrossRefGoogle Scholar
  110. Muir JF, Bertin L, Georges D (1992) Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. Eur Respir J 5: 1197–1200PubMedGoogle Scholar
  111. Neuenkirchen H, Wikens JH, Oellerich M, Sybrecht GW. (1985) Nocturnal asthma: effect of a once per evening dose of sustained-release theophylline. Eur J Respir Dis 66: 196–204PubMedGoogle Scholar
  112. Newman Taylor AN, Longbottom JL, Pepys J (1977) Respiratory allergy to urine proteins of rats and mice. Lancet 2: 847–849Google Scholar
  113. Newman Taylor AN, Davies RJ, Hendrick DJ, Pepys J (1979) Recurrent nocturnal asthmatic reactions to bronchial provocation tests. Clin Allergy 9: 213–219CrossRefGoogle Scholar
  114. Orie NGM, Sluitter HF, Tammeling GJ, DeVries K, Wal AMVD (1964) Fight against bronchitis. In: Orie NGM and Sluitter HR (eds) Bronchitis: 2nd international bronchitis Symposium. Thomas, Springfield IL, pp 352–369Google Scholar
  115. Pauwels R, Van Renerghem D, Van Der Straeten M, Johannesson N, Persson CGA (1985) The effect of theophylline and emprofylline on allergen induced-bronchoconstriction. J Allergy Clin Immunol 76: 583–590PubMedCrossRefGoogle Scholar
  116. Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, Dockhorn RJ, Grossman J, Liddle RF, Yancey SW, Cocchetto DM, Alexander WJ, van As A (1992) A comparison of salmeterol with albuterol in the treatment of mild-tomoderate asthma. N Engl J Med 327: 1420–1425PubMedCrossRefGoogle Scholar
  117. Pedersen B, Dahl R (1990) The effect of salmeterol on the early and late reaction to bronchial allergen challenge and hyperreactivity in patients with bronchial asthma. Clin Exp Allergy 20 (Suppl 1): 94 (abstract)CrossRefGoogle Scholar
  118. Pedersen BK, Laursen LC, Gnosspelius Y, Faurschou P, Weeks B (1985) Bambuterol: effects of a new anti-asthmatic drug. Eur J Clin Pharmacol 29: 425–427PubMedCrossRefGoogle Scholar
  119. Pedersen B, Dahl R, Venge P (1991) The effect of salmeterol on the early and late phase reaction to bronchial allergen challenge and postchallenge variation in bronchial hyperreactivity, blood eosinophils and se-eosinophil cationic protein. Am Rev Respir Dis 143 (4pt2): A649 (Abstract)Google Scholar
  120. Persson CGA (1986) Role of plasma exudation in asthmatic airways. Lancet 2: 1126–1128PubMedCrossRefGoogle Scholar
  121. Persson G, Gnosspelius Y, Anehus S (1988) Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice-daily. Eur Respir J 1: 223–226PubMedGoogle Scholar
  122. Petty TL, Rollins DR, Christopher K, Good JT, Oakley R (1989) Cromolyn sodium is effective in adult chronic asthmatics. Am Rev Respir Dis 139: 694–701PubMedGoogle Scholar
  123. Pierson WE, LaForce CF, Bell TD, MacCosbe PE, Sykes RS, Tinkelman D (1990). Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. J Allergy Clin Immunol 85: 618–626PubMedCrossRefGoogle Scholar
  124. Pincus DJ, Szefler SJ, Ackerson LM, Martin RJ (1995) Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 95: 1172–1178PubMedCrossRefGoogle Scholar
  125. Postma DS, Koeter GH, v.d. Mark TW, Reig RP, Sluiter HJ (1985) The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest 87: 653–657PubMedCrossRefGoogle Scholar
  126. Postma DS, Koeter GH, Keyzer JJ, Meurs H (1986) Influence of slow-release terbutaline on the circadian variation of catecholamines, histamine, and lung function in nonallergic patients with partly reversible airflow obstruction. J Allergy Clin Immunol 77: 471–477PubMedCrossRefGoogle Scholar
  127. Powell ML, Weisberger M, Dowdy Y, Gural R, Symchowicz S, Patrick JE (1987) Comparative steady-state bioavailability of conventional and controlled-release formulations of albuterol. Biopharm Drug Dispos 8: 461–467PubMedCrossRefGoogle Scholar
  128. Reed CE (1991) Aerosol steroids as primary treatment of mild asthma. N Engl J Med 325: 425–426PubMedCrossRefGoogle Scholar
  129. Reinberg A (1989) Chronopharmacology of corticosteroids and ACTH. In. Lemmer B (ed) Chronopharmacology. Cellular and biochemical interactions New York, Marcel Dekker, pp 137–178Google Scholar
  130. Reinberg A, Ghata J, Sidi E (1963) Nocturnal asthma attacks: their relationship to the circadian adrenal cycle. J Allergy 34: 323–330PubMedCrossRefGoogle Scholar
  131. Reinberg A, Gervais P, Morin C, Abulker C (1971) Rhythme circadian humain du seuil de la response bronchique a l’acetylcholine. CR Acad Sci 272: 1879–1881Google Scholar
  132. Reinberg A, Halberg F, Fallers C (1974) Circadian timing of methylprednisolone effects in asthmatic boys. Chronobiologia 1: 333–347PubMedGoogle Scholar
  133. Reinberg A, Guilet P, Gervais P, Ghata J, Vignaud D, Abuker C (1977) One-month chronocorticotherapy (Dutimelan 8–15 mite). Control of the asthmatic condition without adrenal suppression and circadian alteration. Chronobiologia 4: 295–312Google Scholar
  134. Reinberg A, Gervais M, Chaussade G, Fraboulet G, Duburque B (1983) Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergy Clin Immunol 71: 425–433PubMedCrossRefGoogle Scholar
  135. Reinberg A, Pauchet F, Ruff F, Gervais A, Smolensky MH, Levi F, Gervais P, Chaout D, Abella ML, Zidani R (1987) Comparison of once-daily evening versus morning sustained-release theophylline dosing for nocturnal asthma. Chronobiol Intern’l 4: 409–420CrossRefGoogle Scholar
  136. Reinberg A, Smolensky MH, D’Alonzo GE, McGovern JP (1988) Chronobiology and asthma. III Timing corticotherapy to biological rhythms to optimize treatment goals. J Asthma 25: 219–248Google Scholar
  137. Reinberg A, Labrecque G, Smolensky MH (1991) Chronobiologie et chronotherapeu- tique. Heure optimale d’administration des medicaments. Flammarion, ParisGoogle Scholar
  138. Ruffin R, Alpers JH, Kromer DK, Rubinfield AR, Pain MCF, Czarny D, and Bowes G (1986) A 4-week Australian multicentre study of nedocromil sodium in asthmatic patients. Eur J Respir Dis 69 (Suppl 147): 336–339Google Scholar
  139. Ryrfeldt A, Andersson P, Edsbacker S, Tonnesson M, Davies D, Pauwels R (1982) Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis 63 (Suppl.): 86–95Google Scholar
  140. Schulz H-U, Frercks H-J, Hypa F (1984) Vergleichende Theophyllin-Serum-Spiegel Messungen über 24 Stunden nach konventioneller Dosierung einer Theophyllinretard-Präparation über 4 Tage. TherapieWoche 34: 536–543Google Scholar
  141. Serafini U, Bonini S (1974) Corticoid therapy in allergic disease. Clinical evaluation of a chronopharmacological attempt. Chronobiologia 1 (Suppl 1): 339–406Google Scholar
  142. Sheffer AL (1991) National Heart, Lung and Blood Institute. National Asthma Education Program. Expert Panel Report: Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 88: 425–534CrossRefGoogle Scholar
  143. Sheffer AL (1992) International consensus report on diagnosis and management of asthma. Eur Respir J 5: 601–641Google Scholar
  144. Sly PD, Landau LI, Olinsky A (1987) Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children. Thorax 42: 357–60.PubMedCrossRefGoogle Scholar
  145. Smith E (1860) Recherches experimentales sur la respiration. J Physiol de l’ Homme et des Animaux 3: 506–21Google Scholar
  146. Smolensky MH (1989) Chronopharmacolgy of theophylline and beta-sympathomimetics. In: Lemmer B (ed) Chronopharmacology. Cellular and biochemical interactions. Marcel Dekker, NY, pp 65–113Google Scholar
  147. Smolensky MH, D’Alonzo GE (1993) Medical chronobiology: concepts and applications. Amer Rev Res Dis 147: 511–519Google Scholar
  148. Smolensky MH, Barnes PJ, Reinberg A, McGovern JP (1986) Chronobiology and asthma. I. Day-night differences in bronchial patency and dyspnea and circadian rthythm dependencies. J Asthma 23: 321–343Google Scholar
  149. Smolensky MH, McGovern JP, Scott PH, Reinberg A (1987a) Chronobiology and asthma. II. Body-time-dependent differences in the kinetics and effects of bronchodilator medications. J Asthma 24: 90–134Google Scholar
  150. Smolensky MH, Scott PH, Harrist RB, Hiatt PH, Wong TK, Baenziger JC, Klank BJ, Marbella A, Meltzer A (1987b) Administration-time-dependency of the pharmacokinetic behavior and therapeutic effect of a once-a-day theophylline in asthmatic children. Chronobiol Intern’l 4: 435–448CrossRefGoogle Scholar
  151. Smolensky MH, Reinberg A, Labrecque G (1995) Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implication. J Allergy Clin Immunol 95: 1084–1096PubMedCrossRefGoogle Scholar
  152. Soutar CA, Costello J, Ijaduola O, Turner-Warwick M (1975) Nocturnal and morning asthma. Relationship to plasma corticosteroids and response to cortisol infusion. Thorax 30: 436–440Google Scholar
  153. Soutar CA, Carruthers M, Pickering CA (1977) Nocturnal asthma and urinary adrenaline and nor-adrenaline excretion. Thorax 32: 677–683PubMedCrossRefGoogle Scholar
  154. Steinijans VW, Schulz H-U, Beier W, Radtke HW (1986) Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet ( Uniphyllin ). Intern’l J Clin Pharmacol 24: 43–47Google Scholar
  155. Stewart IC, Rhind GB, Power JT, Flenley DC, Douglas NJ (1987) Effect of sustained release terbutaline on symptoms and sleep quality in patients with nocturnal asthma. Thorax 42: 797–800PubMedCrossRefGoogle Scholar
  156. Storms WW, Nathan RA, Bodman SF, Morris RJ, Morris RJ, Selner JC, Greenstein SM, Zwillich CW (1992) The effect of repeat action albuterol sulfate (Proventil Repetabs) in nocturnal symptoms of asthma. J. Asthma 29: 209–216Google Scholar
  157. Storms WW, Bodman SF, Nathan RA, Byer P (1994) Nocturnal asthma symptoms may be more prevalent than we think. J Asthma 31: 313–318PubMedCrossRefGoogle Scholar
  158. Sullivan P, Songul B, Jaffar Z, Page C. Jeffery P, Costello J (1994) Anti-inflammatory effects of low dose oral theophylline in atopic asthma. Lancet 343: 1006–1008PubMedCrossRefGoogle Scholar
  159. Sur S, Mohiuddin AA, Vichyanond P, Nelson HS (1990) A random double-blind trial of the combination of nebulized atropine methylnitrate and albuterol in nocturnal asthma. Ann Allergy 65: 384–388PubMedGoogle Scholar
  160. Sykes RS, Reese ME, Meyer MC, Chubb JM (1988) Relative bioavailability of a controlled-release albuterol formulation for twice-daily use. Biopharm Drug Dispos 9: 551–556PubMedCrossRefGoogle Scholar
  161. Tan WC, Martin RJ, Pandey R, Ballard RD (1990) Effects of spontaneous and stimulated gastroesophageal reflux on sleeping asthmatics. Am Rev Respir Dis 141: 1394–1399PubMedGoogle Scholar
  162. Toogood JH, Baskerville JC, Jennings B, Lefco NM, Johansson SA (1982) Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 70: 288–298PubMedCrossRefGoogle Scholar
  163. Torvik JA, Borish LC, Beam WR, Kraft M, Wenzel SE, Martin RJ (1994) Does theophylline alter inflammation in nocturnal asthma? Am J Respir Crit Care Med 149: A210 (Abstract)Google Scholar
  164. Trudeau JB, Martin RJ, Kraft M, Torvik JA, Westcott JY, Wenzel SE (1994) Theophylline decreases stimulated alveolar macrophage leukotriene B4 (LTB4) production in nocturnal asthmatics lavaged at 4 a.m. Am J Respir Crit Care Med 149: A941 (Abstract)Google Scholar
  165. Trousseau A (1865) Clinique Medicale de l’Hopital Dieu de Paris, vol. 2. Asthme. Bailliere, Paris, p 373Google Scholar
  166. Turner-Warwick M (1988) Epidemiology of nocturnal asthma. Am J Med 85 (Suppl 1B): 6–8PubMedCrossRefGoogle Scholar
  167. Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST (1990) Protection against allergen-induced asthma by salmeterol. Lancet 336: 1338–1342PubMedCrossRefGoogle Scholar
  168. Ullman A, Svedmyr N (1988) Salmeterol, a new long acting inhaled beta2-adrenoreceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 43: 674–678PubMedCrossRefGoogle Scholar
  169. Ullman A, Hedner J, Svedmyr N (1990) Inhaled salmeterol and salbutamol in asthmatic patients. Am Rev Resp Dis 142: 571–575PubMedCrossRefGoogle Scholar
  170. Vener KJ, Moore JG (1988) Chronobiologic properties of the alimentary canal affecting xenobiotic absorption. Ann Rev Chronopharmacol 4: 259–283Google Scholar
  171. Ward AJM, McKenniff M, Evans JM, Page CP, Costello JF (1993) Theopylline — an immunomodulatory role in asthma? Am Rev Respir Dis 147: 518–523PubMedGoogle Scholar
  172. Warren JB, Cuss F, Barnes PJ (1985) Posture and theophylline kinetics. Br J Clin Pharmacol 19: 707–709PubMedCrossRefGoogle Scholar
  173. Wettengel R, Berdel D, Cegla U, Fabel H, Geisler L, Hofmann D, Krause J, Kroidl RF, Lanser K, Leupold W, et al. (1994) Empfehlungen der Deutschen Atemwegsliga zum Asthmamanagement bei Erwachsenen und bei Kindern Med. Klinik. 89: 57–67Google Scholar
  174. Whelan CJ, Johnson M (1992) Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol 101 (Suppl): 528P (Abstract)Google Scholar
  175. Williams AJ, Stableforth D (1986) The addition of nedocromil sodium to maintenance therapy in the management of patients with bronchial asthma. Eur J Respir Dis 69 (Suppl 147): 340–343Google Scholar
  176. Wolstenholme RJ, Shettan SP (1989) Comparison of a combination of fenoterol with ipratropium bromide ( Duovent) and salbutamol in young adults with nocturnal asthma. Respiration 55: 152–157Google Scholar
  177. Wulfsohn NL, Politzer WM (1964) Bronchial asthma during menses and pregnancy. S Afr Med J 38: 173PubMedGoogle Scholar
  178. Wurthwein G, Rohdewald P (1990) Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate. Biopharm Drug Disposition 11: 381–394CrossRefGoogle Scholar
  179. Zwillich CW, Neagley SR, Cicutto L, White DP, Martin RJ (1989) Nocturnal asthma therapy: inhaled bitolterol versus sustained-release theophylline. Am Rev Respir Dis 139: 470–474PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • M. H. Smolensky
  • G. E. D’Alonzo

There are no affiliations available

Personalised recommendations